HSS Journal

, Volume 6, Issue 2, pp 190–198 | Cite as

Alternative Procedures for Reducing Allogeneic Blood Transfusion in Elective Orthopedic Surgery

  • Kathrin Kleinert
  • Oliver M. Theusinger
  • Johannes Nuernberg
  • Clément M. L. Werner
Review Article

Abstract

Perioperative blood loss is a major problem in elective orthopedic surgery. Allogeneic transfusion is the standard treatment for perioperative blood loss resulting in low postoperative hemoglobin, but it has a number of well-recognized risks, complications, and costs. Alternatives to allogeneic blood transfusion include preoperative autologous donation and intraoperative salvage with postoperative autotransfusion. Orthopedic surgeons are often unaware of the different pre- and intraoperative possibilities of reducing blood loss and leave the management of coagulation and use of blood products completely to the anesthesiologists. The goal of this review is to compare alternatives to allogeneic blood transfusion from an orthopedic and anesthesia point of view focusing on estimated costs and acceptance by both parties.

Keywords

allogeneic blood transfusion blood loss elective orthopedic surgery autologous blood transfusion predonation hemodilution EPO iv iron fibrin sealant platelet gel 

References

  1. 1.
    Anderson L, Quasim I, Soutar R, Steven M, Macfie A, Korte W, An audit of red cell and blood product use after the institution of thromboelastometry in a cardiac intensive care unit. Transfus. Med. 2006; 16(1): 31–39PubMedCrossRefGoogle Scholar
  2. 2.
    Andersson I, Tylman M, Bengtson JP, Bengtsson A, Complement split products and pro-inflammatory cytokines in salvaged blood after hip and knee arthroplasty. Can. J. Anaesth. 2001; 48(3): 251–255PubMedCrossRefGoogle Scholar
  3. 3.
    Anonym, Effectiveness of perioperative recombinant human erythropoietin in elective hip replacement. Canadian Orthopedic Perioperative Erythropoietin Study Group. Lancet. 1993; 341(8855): 1227–1232Google Scholar
  4. 4.
    Beck-Schimmer B, Romero B, Booy C, Joch H, Hallers U, Pasch T, Spahn DR, Release of inflammatory mediators in irradiated cell salvage blood and their biological consequences in human beings following transfusion. Eur. J. Anaesthesiol. 2004; 21(1): 46–52PubMedGoogle Scholar
  5. 5.
    Bennett J, Haynes S, Torella F, Grainger H, McCollum C, Acute normovolemic hemodilution in moderate blood loss surgery: a randomized controlled trial. Transfusion. 2006; 46(7): 1097–1103PubMedCrossRefGoogle Scholar
  6. 6.
    Beris P, Munoz M, Garcia-Erce JA, Thomas D, Maniatis A, Van der Linden P, Perioperative anaemia management: consensus statement on the role of intravenous iron. Br. J. Anaesth. 2008; 100(5): 599–604PubMedCrossRefGoogle Scholar
  7. 7.
    Blumberg N, Heal JM, Effects of transfusion on immune function. Cancer recurrence and infection. Arch. Pathol. Lab. Med. 1994; 118(4): 371–379PubMedGoogle Scholar
  8. 8.
    Borghi B, Casati A, Incidence and risk factors for allogenic blood transfusion during major joint replacement using an integrated autotransfusion regimen. The Rizzoli Study Group on Orthopaedic Anaesthesia. Eur. J. Anaesthesiol. 2000; 17(7): 411–417PubMedGoogle Scholar
  9. 9.
    Bryson GL, Laupacis A, Wells GA, Does acute normovolemic hemodilution reduce perioperative allogeneic transfusion? A meta-analysis. The International Study of Perioperative Transfusion. Anesth. Analg. 1998; 86(1): 9–15PubMedCrossRefGoogle Scholar
  10. 10.
    Chassot PG, Delabays A, Spahn DR, Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction. Br. J. Anaesth. 2007; 99(3): 316–328PubMedCrossRefGoogle Scholar
  11. 11.
    Chassot PG, Delabays A, Spahn DR, Perioperative use of anti-platelet drugs. Best Pract. Res. Clin. Anaesthesiol. 2007; 21(2): 241–256PubMedCrossRefGoogle Scholar
  12. 12.
    Chertow GM, Mason PD, Vaage-Nilsen O, Ahlmen J, Update on adverse drug events associated with parenteral iron. Nephrol. Dial. Transplant. 2006; 21(2): 378–382PubMedCrossRefGoogle Scholar
  13. 13.
    Chun TY, Martin S, Lepor H, Preoperative recombinant human erythropoietin injection versus preoperative autologous blood donation in patients undergoing radical retropubic prostatectomy. Urology. 1997; 50(5): 727–732PubMedCrossRefGoogle Scholar
  14. 14.
    Claridge JA, Sawyer RG, Schulman AM, McLemore EC, Young JS, Blood transfusions correlate with infections in trauma patients in a dose-dependent manner. Am. Surg. 2002; 68(7): 566–572PubMedGoogle Scholar
  15. 15.
    Coyne DW, Kapoian T, Suki W, Singh AK, Moran JE, Dahl NV, Rizkala AR, Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) Study. J. Am. Soc. Nephrol. 2007; 18(3): 975–984PubMedCrossRefGoogle Scholar
  16. 16.
    Cuenca J, Garcia-Erce JA, Martinez F, Perez-Serrano L, Herrera A, Munoz M, Perioperative intravenous iron, with or without erythropoietin, plus restrictive transfusion protocol reduce the need for allogeneic blood after knee replacement surgery. Transfusion. 2006; 46(7): 1112–1119PubMedCrossRefGoogle Scholar
  17. 17.
    Cuenca J, Garcia-Erce JA, Martinez AA, Solano VM, Molina J, Munoz M, Role of parenteral iron in the management of anaemia in the elderly patient undergoing displaced subcapital hip fracture repair: preliminary data. Arch. Orthop. Trauma. Surg. 2005; 125(5): 342–347PubMedCrossRefGoogle Scholar
  18. 18.
    Cuenca J, Garcia-Erce JA, Munoz M, Izuel M, Martinez AA, Herrera A, Patients with pertrochanteric hip fracture may benefit from preoperative intravenous iron therapy: a pilot study. Transfusion. 2004; 44(10): 1447–1452PubMedCrossRefGoogle Scholar
  19. 19.
    Dahl NV, Henry DH, Coyne DW, Thrombosis with erythropoietic stimulating agents—does iron-deficient erythropoiesis play a role? Semin. Dial. 2008; 21(3): 210–211PubMedCrossRefGoogle Scholar
  20. 20.
    Dai B, Wang L, Djaiani G, Mazer CD. Continuous and discontinuous cell-washing autotransfusion systems. J. Cardiothorac. Vasc. Anesth. 2004; 18(2): 210–217PubMedCrossRefGoogle Scholar
  21. 21.
    Diez-Lobo AI, Preoperative intravenous iron administration corrects anemia and reduces transfusion requirement in women undergoing abdominal hysterectomy. Transfusion Alternatives in Transfusion Medicine. 2007; 9(2): 114–119CrossRefGoogle Scholar
  22. 22.
    Dodd RY, The risk of transfusion-transmitted infection. N. Engl. J. Med. 1992; 327(6): 419–421PubMedCrossRefGoogle Scholar
  23. 23.
    Dodd RY, Current risk for transfusion transmitted infections. Curr. Opin. Hematol. 2007; 14(6): 671–676PubMedGoogle Scholar
  24. 24.
    Duffy G, Neal KR, Differences in post-operative infection rates between patients receiving autologous and allogeneic blood transfusion: a meta-analysis of published randomized and nonrandomized studies. Transfus. Med. 1996; 6(4): 325–328PubMedCrossRefGoogle Scholar
  25. 25.
    Earley AS, Gracias VH, Haut E, Sicoutris CP, Wiebe DJ, Reilly PM, Schwab CW, Anemia management program reduces transfusion volumes, incidence of ventilator-associated pneumonia, and cost in trauma patients. J. Trauma. 2006; 61(1): 1–5. discussion 5–7PubMedCrossRefGoogle Scholar
  26. 26.
    Eroglu A, Uzunlar H, Erciyes N, Comparison of hypotensive epidural anesthesia and hypotensive total intravenous anesthesia on intraoperative blood loss during total hip replacement. J. Clin. Anesth. 2005; 17(6): 420–425PubMedCrossRefGoogle Scholar
  27. 27.
    Erslev AJ, Erythropoietin. N. Engl. J. Med. 1991; 324(19): 1339–1344PubMedCrossRefGoogle Scholar
  28. 28.
    Everts PA, Devilee RJ, Brown Mahoney C, Eeftinck-Schattenkerk M, Box HA, Knape JT, van Zundert A, Platelet gel and fibrin sealant reduce allogeneic blood transfusions in total knee arthroplasty. Acta. Anaesthesiol. Scand. 2006; 50(5): 593–599PubMedCrossRefGoogle Scholar
  29. 29.
    Ferraris VA et al, Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline. Ann. Thorac. Surg. 2007; 83(5 Suppl): S27–S86PubMedCrossRefGoogle Scholar
  30. 30.
    Fopp M, Sicherheit der Bluttransfusion heute. Schweiz. Med. Forum 2006; 6: 139–144.Google Scholar
  31. 31.
    Franchini M, Targher G, Montagnana M, Lippi G, Iron and thrombosis. Ann. Hematol. 2008; 87(3): 167–173PubMedCrossRefGoogle Scholar
  32. 32.
    Fries D, Haas T, Klingler A, Streif W, Klima G, Martini J, Wagner-Berger H, Innerhofer P, Efficacy of fibrinogen and prothrombin complex concentrate used to reverse dilutional coagulopathy—a porcine model. Br. J. Anaesth. 2006; 97(4): 460–467PubMedCrossRefGoogle Scholar
  33. 33.
    Fries D, Krismer A, Klingler A, Streif W, Klima G, Wenzel V, Haas T, Innerhofer P, Effect of fibrinogen on reversal of dilutional coagulopathy: a porcine model. Br. J. Anaesth. 2005; 95(2): 172–177PubMedCrossRefGoogle Scholar
  34. 34.
    Ganter MT, Hofer CK, Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices. Anesth. Analg. 2008; 106(5): 1366–1375PubMedCrossRefGoogle Scholar
  35. 35.
    Goldman M, Remy-Prince S, Trepanier A, Decary F, Autologous donation error rates in Canada. Transfusion. 1997; 37(5): 523–527PubMedCrossRefGoogle Scholar
  36. 36.
    Goodnough LT, Monk TG, Despotis GJ, Merkel K, A randomized trial of acute normovolemic hemodilution compared to preoperative autologous blood donation in total knee arthroplasty. Vox. Sang. 1999; 77(1): 11–16PubMedCrossRefGoogle Scholar
  37. 37.
    Goodnough LT, Shander A, Brecher ME, Transfusion medicine: looking to the future. Lancet. 2003; 361(9352): 161–169PubMedCrossRefGoogle Scholar
  38. 38.
    Goodnough LT, Skikne B, Brugnara C, Erythropoietin, iron, and erythropoiesis. Blood. 2000; 96(3): 823–833PubMedGoogle Scholar
  39. 39.
    Habler O, Meier J, Pape A, Kertscho H, Zwissler B, [Tolerance to perioperative anemia. Mechanisms, influencing factors and limits]. Orthopade. 2007; 36(8): 763–776. quiz 777–778PubMedCrossRefGoogle Scholar
  40. 40.
    Habler O, Messmer K, [Methods for reduction of homologous blood transfusions in operative medicine]. Anaesthesist. 1997; 46(11): 915–926PubMedCrossRefGoogle Scholar
  41. 41.
    Habler O et al, Effects of standardized acute normovolemic hemodilution on intraoperative allogeneic blood transfusion in patients undergoing major maxillofacial surgery. Int. J. Oral Maxillofac. Surg. 2004; 33(5): 467–475PubMedCrossRefGoogle Scholar
  42. 42.
    Healy JC, Frankforter SA, Graves BK, Reddy RL, Beck JR, Preoperative autologous blood donation in total-hip arthroplasty. A cost–effectiveness analysis. Arch. Pathol. Lab. Med. 1994; 118(4): 465–470PubMedGoogle Scholar
  43. 43.
    Heddle NM, Brox WT, Klama LN, Dickson LL, Levine MN, A randomized trial on the efficacy of an autologous blood drainage and transfusion device in patients undergoing elective knee arthroplasty. Transfusion. 1992; 32(8): 742–746PubMedCrossRefGoogle Scholar
  44. 44.
    Henry DA, Carless PA, Moxey AJ, O'Connell D, Forgie MA, Wells PS, Fergusson D, Pre-operative autologous donation for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst. Rev. 2002; (2): CD003602Google Scholar
  45. 45.
    Hill GE, Frawley WH, Griffith KE, Forestner JE, Minei JP, Allogeneic blood transfusion increases the risk of postoperative bacterial infection: a meta-analysis. J. Trauma. 2003; 54(5): 908–914PubMedCrossRefGoogle Scholar
  46. 46.
    Ishii Y, Matsuda Y, Effect of the timing of tourniquet release on perioperative blood loss associated with cementless total knee arthroplasty: a prospective randomized study. J. Arthroplasty. 2005; 20(8): 977–983PubMedCrossRefGoogle Scholar
  47. 47.
    Jelkmann W, Developments in the therapeutic use of erythropoiesis stimulating agents. Br. J. Haematol. 2008; 141(3): 287–297PubMedCrossRefGoogle Scholar
  48. 48.
    Juelsgaard P, Larsen UT, Sorensen JV, Madsen F, Soballe K, Hypotensive epidural anesthesia in total knee replacement without tourniquet: reduced blood loss and transfusion. Reg. Anesth. Pain Med. 2001; 26(2): 105–110PubMedGoogle Scholar
  49. 49.
    Karger R, Kretschmer V, Modern concepts of autologous haemotherapy. Transfus. Apher. Sci. 2005; 32(2): 185–196PubMedCrossRefGoogle Scholar
  50. 50.
    Kjaergard HK, Fairbrother JE, Controlled clinical studies of fibrin sealant in cardiothoracic surgery—a review. Eur. J. Cardiothorac. Surg. 1996; 10(9): 727–733PubMedCrossRefGoogle Scholar
  51. 51.
    Klein HG, Spahn DR, Carson JL, Red blood cell transfusion in clinical practice. Lancet. 2007; 370(9585): 415–426PubMedCrossRefGoogle Scholar
  52. 52.
    Kopko PM, Holland PV, Transfusion-related acute lung injury. Br. J. Haematol. 1999; 105(2): 322–329PubMedCrossRefGoogle Scholar
  53. 53.
    Kulnigg S, Stoinov S, Simanenkov V, Dudar LV, Karnafel W, Garcia LC, Sambuelli AM, D'Haens G, Gasche C, A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial. Am. J. Gastroenterol. 2008; 103(5): 1182–1192PubMedCrossRefGoogle Scholar
  54. 54.
    Larkin M, Value of preoperative autologous blood donation questioned. The Lancet. 2002; 360: 696CrossRefGoogle Scholar
  55. 55.
    Levy O, Martinowitz U, Oran A, Tauber C, Horoszowski H, The use of fibrin tissue adhesive to reduce blood loss and the need for blood transfusion after total knee arthroplasty. A prospective, randomized, multicenter study. J. Bone Joint Surg. Am. 1999; 81(11): 1580–1588PubMedGoogle Scholar
  56. 56.
    Lincoln JA, Lefkowitz DL, Cain T, Castro A, Mills KC, Lefkowitz SS, Moguilevsky N, Bollen A, Exogenous myeloperoxidase enhances bacterial phagocytosis and intracellular killing by macrophages. Infect. Immun. 1995; 63(8): 3042–3047PubMedGoogle Scholar
  57. 57.
    Luddington RJ, Thrombelastography/thromboelastometry. Clin. Lab. Haematol. 2005; 27(2): 81–90PubMedCrossRefGoogle Scholar
  58. 58.
    Madjdpour C, Spahn DR, Allogeneic red blood cell transfusions: efficacy, risks, alternatives and indications. Br. J. Anaesth. 2005; 95(1): 33–42PubMedCrossRefGoogle Scholar
  59. 59.
    Mankad PS, Codispoti M, The role of fibrin sealants in hemostasis. Am. J. Surg. 2001; 182(2 Suppl): 21S–28SPubMedGoogle Scholar
  60. 60.
    Marik PE, Corwin HL, Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature. Crit. Care Med. 2008; 36(9): 2667–2674PubMedCrossRefGoogle Scholar
  61. 61.
    Matot I, Scheinin O, Jurim O, Eid A, Effectiveness of acute normovolemic hemodilution to minimize allogeneic blood transfusion in major liver resections. Anesthesiology. 2002; 97(4): 794–800PubMedCrossRefGoogle Scholar
  62. 62.
    McShane AJ, Martin JL, Preoxygenation and pulse oximetry may delay detection of esophageal intubation. J. Natl. Med. Assoc. 1987; 79(9): 991–992Google Scholar
  63. 63.
    Messmer K, Consensus statement: using epoetin alfa to decrease the risk of allogeneic blood transfusion in the surgical setting. Roundtable of Experts in Surgery Blood Management. Semin. Hematol. 1996; 33(2 Suppl 2): 78–80PubMedGoogle Scholar
  64. 64.
    Monk TG, Goodnough LT, Brecher ME, Colberg JW, Andriole GL, Catalona WJ, A prospective randomized comparison of three blood conservation strategies for radical prostatectomy. Anesthesiology. 1999; 91(1): 24–33PubMedCrossRefGoogle Scholar
  65. 65.
    Moonen AF, Knoors NT, van Os JJ, Verburg AD, Pilot P, Retransfusion of filtered shed blood in primary total hip and knee arthroplasty: a prospective randomized clinical trial. Transfusion. 2007; 47(3): 379–384PubMedCrossRefGoogle Scholar
  66. 66.
    Moonen AF, Neal TD, Pilot P, Peri-operative blood management in elective orthopaedic surgery. A critical review of the literature. Injury. 37(Suppl 5): S11–S16PubMedCrossRefGoogle Scholar
  67. 67.
    Morgan GE Jr, Mikhail MS, Murray MJ, Larson P Jr (eds), Geriatric anesthesia. In: Clinical Anesthesiology. New York: McGraw-Hill; 2002:875–881.Google Scholar
  68. 68.
    Mustoe TA, Pierce GF, Thomason A, Gramates P, Sporn MB, Deuel TF, Accelerated healing of incisional wounds in rats induced by transforming growth factor-beta. Science. 1987; 237(4820): 1333–1336PubMedCrossRefGoogle Scholar
  69. 69.
    Nelson CL, Bowen WS, Total hip arthroplasty in Jehovah's Witnesses without blood transfusion. J. Bone Joint Surg. Am. 1986; 68(3): 350–353PubMedGoogle Scholar
  70. 70.
    Niemi TT, Pitkanen M, Syrjala M, Rosenberg PH, Comparison of hypotensive epidural anaesthesia and spinal anaesthesia on blood loss and coagulation during and after total hip arthroplasty. Acta. Anaesthesiol. Scand. 2000; 44(4): 457–464PubMedCrossRefGoogle Scholar
  71. 71.
    Pape A, Habler O, Alternatives to allogeneic blood transfusions. Best. Pract. Res. Clin. Anaesthesiol. 2007; 21(2): 221–239PubMedCrossRefGoogle Scholar
  72. 72.
    Pierce GF, Mustoe TA, Lingelbach J, Masakowski VR, Griffin GL, Senior RM, Deuel TF, Platelet-derived growth factor and transforming growth factor-beta enhance tissue repair activities by unique mechanisms. J. Cell Biol. 1989; 109(1): 429–440PubMedCrossRefGoogle Scholar
  73. 73.
    Reize P, Wulker N, [Foreign blood saving measures in orthopedic surgery]. Orthopade. 2007; 36(6): 537–543PubMedCrossRefGoogle Scholar
  74. 74.
    Rosencher N, Kerkkamp HE, Macheras G, Munuera LM, Menichella G, Barton DM, Cremers S, Abraham IL, Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion. 2003; 43(4): 459–469PubMedCrossRefGoogle Scholar
  75. 75.
    Sans T, Bofill C, JJ, Effectiveness of very low doses of subcutaneous recombinant human erythropoietin in facilitating autologous blood donation before orthopedic surgery. Transfusion. 1996; 36: 822–826PubMedCrossRefGoogle Scholar
  76. 76.
    Schmied H, Kurz A, Sessler DI, Kozek S, Reiter A, Mild hypothermia increases blood loss and transfusion requirements during total hip arthroplasty. Lancet. 1996; 347(8997): 289–292PubMedCrossRefGoogle Scholar
  77. 77.
    Segal JB, Blasco-Colmenares E, Norris EJ, Guallar E, Preoperative acute normovolemic hemodilution: a meta-analysis. Transfusion. 2004; 44(5): 632–644PubMedCrossRefGoogle Scholar
  78. 78.
    Shander A, Hofmann A, Gombotz H, Theusinger OM, Spahn DR, Estimating the cost of blood: past, present, and future directions. Best Pract. Res. Clin. Anaesthesiol. 2007; 21(2): 271–289PubMedCrossRefGoogle Scholar
  79. 79.
    Shore-Lesserson L, Manspeizer HE, DePerio M, Francis S, Vela-Cantos F, Ergin MA, Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery. Anesth. Analg. 1999; 88(2): 312–319PubMedCrossRefGoogle Scholar
  80. 80.
    Slappendel R, Weber EW, Benraad B, Dirksen R, Bugter ML, Does ibuprofen increase perioperative blood loss during hip arthroplasty? Eur. J. Anaesthesiol. 2002; 19(11): 829–831PubMedGoogle Scholar
  81. 81.
    Spahn DR, Casutt M, Eliminating blood transfusions: new aspects and perspectives. Anesthesiology. 2000; 93(1): 242–255PubMedCrossRefGoogle Scholar
  82. 82.
    Spahn DR, Chassot PG, Zaugg M, Pragmatic treatment versus elaborative but incomplete testing: a Hobson's choice? Anesthesiology. 2007; 107(4): 526–529PubMedCrossRefGoogle Scholar
  83. 83.
    Spahn DR, Howell SJ, Delabays A, Chassot PG, Coronary stents and perioperative anti-platelet regimen: dilemma of bleeding and stent thrombosis. Br. J. Anaesth. 2006; 96(6): 675–677PubMedCrossRefGoogle Scholar
  84. 84.
    Spalding GJ, Hartrumpf M, Sierig T, Oesberg N, Kirschke CG, Albes JM, [Bedside thrombelastography. Cost reduction in cardiac surgery]. Anaesthesist. 2007; 56(8): 765–771PubMedCrossRefGoogle Scholar
  85. 85.
    Spence RK, Emerging trends in surgical blood transfusion. Semin. Hematol. 1997; 34(3 Suppl 2): 48–53PubMedGoogle Scholar
  86. 86.
    Tartter PI, Quintero S, Barron DM, Perioperative blood transfusion associated with infectious complications after colorectal cancer operations. Am. J. Surg. 1986; 152(5): 479–482PubMedCrossRefGoogle Scholar
  87. 87.
    Tenholder M, Cushner FD, Intraoperative blood management in joint replacement surgery. Orthopedics. 2004; 27(6 Suppl): s663–s668PubMedGoogle Scholar
  88. 88.
    Terada N, Arai Y, Matsuta Y, Maekawa S, Okubo K, Ogura K, Matsuda N, Yonei A, Acute normovolemic hemodilution for radical prostatectomy: can it replace preoperative autologous blood transfusion? 2001; Int. J. Urol. 2001; 8(4): 149–152PubMedCrossRefGoogle Scholar
  89. 89.
    Theusinger OM, Leyvraz PF, Schanz U, Seifert B, Spahn DR, Treatment of iron deficiency anemia in orthopedic surgery with intravenous iron: efficacy and limits: a prospective study. Anesthesiology. 2007; 107(6): 923–927PubMedCrossRefGoogle Scholar
  90. 90.
    Triulzi DJ, Blumberg N, Heal JM, Association of transfusion with postoperative bacterial infection. Crit. Rev. Clin. Lab. Sci. 1990; 28(2): 95–107PubMedCrossRefGoogle Scholar
  91. 91.
    Vamvakas EC, Perioperative blood transfusion and cancer recurrence: meta-analysis for explanation. Transfusion. 1995; 35(9): 760–768PubMedCrossRefGoogle Scholar
  92. 92.
    Vamvakas EC, Moore SB, Cabanela M, Blood transfusion and septic complications after hip replacement surgery. Transfusion. 1995; 35(2): 150–156PubMedCrossRefGoogle Scholar
  93. 93.
    Vamvakas EC, Pineda AA, Autologous transfusion and other approaches to reduce allogeneic blood exposure. Baillieres Best Pract. Res. Clin. Haematol. 2000; 13(4): 533–547PubMedGoogle Scholar
  94. 94.
    Varney SJ, Guest JF, The annual cost of blood transfusions in the UK. Transfus. Med. 2003; 13(4): 205–218PubMedCrossRefGoogle Scholar
  95. 95.
    Wang GJ, Hungerford DS, Savory CG, Rosenberg AG, Mont MA, Burks SG, Mayers SL, Spotnitz WD, Use of fibrin sealant to reduce bloody drainage and hemoglobin loss after total knee arthroplasty: a brief note on a randomized prospective trial. J. Bone. Joint. Surg. Am. 2001; 83–A(10): 1503–1505PubMedGoogle Scholar
  96. 96.
    Weber EW, Slappendel R, Durieux ME, Dirksen R, van der Heide H, Spruit M, COX 2 selectivity of non-steroidal anti-inflammatory drugs and perioperative blood loss in hip surgery. A randomized comparison of indomethacin and meloxicam. Eur. J. Anaesthesiol. 2003; 20(12): 963–966PubMedCrossRefGoogle Scholar
  97. 97.
    Weiskopf RB, Aminoff MJ, Hopf HW, Feiner J, Viele MK, Watson JJ, Ho R, Songster C, Toy P, Acute isovolemic anemia does not impair peripheral or central nerve conduction. Anesthesiology. 2003; 99(3): 546–551PubMedCrossRefGoogle Scholar
  98. 98.
    Weiss G, Goodnough LT, Anemia of chronic disease. N. Engl. J. Med. 2005; 352(10): 1011–1023PubMedCrossRefGoogle Scholar
  99. 99.
    Winkler M et al. Aggressive warming reduces blood loss during hip arthroplasty. Anesth. Analg. 2000; 91(4): 978–984PubMedCrossRefGoogle Scholar
  100. 100.
    Wong JC, Torella F, Haynes SL, Dalrymple K, Mortimer AJ, McCollum CN, Autologous versus allogeneic transfusion in aortic surgery: a multicenter randomized clinical trial. Ann. Surg. 2002; 235(1): 145–151PubMedCrossRefGoogle Scholar
  101. 101.
    Woolson ST, Pottorff G, Use of preoperatively deposited autologous blood for total knee replacement. Orthopedics. 1993; 16(2): 137–141. discussion 141–2PubMedGoogle Scholar
  102. 102.
    Woolson ST, Watt JM, Use of autologous blood in total hip replacement. A comprehensive program. J. Bone Joint Surg. Am. 1991; 73(1): 76–80PubMedGoogle Scholar
  103. 103.
    Wrotniak M, Bielecki T, Gazdzik TS, Current opinion about using the platelet-rich gel in orthopaedics and trauma surgery. Ortop. Traumatol. Rehabil. 2007; 9(3): 227–238PubMedGoogle Scholar

Copyright information

© Hospital for Special Surgery 2009

Authors and Affiliations

  • Kathrin Kleinert
    • 1
  • Oliver M. Theusinger
    • 2
  • Johannes Nuernberg
    • 2
  • Clément M. L. Werner
    • 1
    • 3
  1. 1.Department of Orthopaedics, Balgrist University HospitalUniversity of ZurichZurichSwitzerland
  2. 2.Institute of Anaesthesiology, University Hospital ZurichUniversity of ZurichZurichSwitzerland
  3. 3.Division of Trauma Surgery, Department of SurgeryUniversity Hospital ZurichZurichSwitzerland

Personalised recommendations